Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86,723,804
-
Total 13F shares
-
533,823
-
Share change
-
-138,805
-
Total reported value
-
$1,697,581
-
Price per share
-
$3.18
-
Number of holders
-
13
-
Value change
-
-$884,134
-
Number of buys
-
6
-
Number of sells
-
7
Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q4 2022
As of 31 Dec 2022,
Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
533,823 shares.
The largest 10 holders included
FMR LLC, JPMORGAN CHASE & CO, CITIGROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, Summit Trail Advisors, LLC, Financial Guidance Group, Inc., Opal Wealth Advisors, LLC, and Tower View Investment Management & Research LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.